KaloBios
about uspipelineclinical trialshumaneeringcareersnews roomcontact us
Pipeline

KB004

Humaneered™ IgG1k antibody that binds to a receptor tyrosine kinase expressed on the surface of tumor cells. This antibody is being developed for the treatment of solid tumors.

Antibody binds to a wide range of solid tumors. Activity demonstrated in human tumors in mice Humaneered™ antibody being generated



<-- Return to Pipeline